Diagnostic Value of Common Inflammatory Markers on Fever of Unknown Origin
|
|
- Erik Joseph
- 6 years ago
- Views:
Transcription
1 Jpn. J. Infect. Dis., 69, , 2016 Original Article Diagnostic Value of Common Inflammatory Markers on Fever of Unknown Origin Cui-Ping Liu 1,Zhi-YongLiu 2, Jun-Ping Liu 1, Yi Kang 1, Chong-Shan Mao 1, and Jia Shang 1 * 1 Department of Infectious Diseases, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan; and 2 Department of Bone and Soft Tumor, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Henan, China SUMMARY: This study wasdesigned toevaluate the diagnostic value of common inflammatory markers with regard to fever of unknown origin (FUO). We investigated 383 patients who were hospitalized with FUO at the Henan Province People's hospital between January 2009 and June Of all the cases, infectious diseases accounted for 33.9z, neoplasms for 21.1z, collagen vascular diseases for 25.1z, miscellaneous diseases for 4.7z, and no diagnosis for 15.1z. Patients in the neoplasm group were older than those in the infectious disease, collagen vascular disease, and miscellaneous disease groups (p = 0.006, p < , and p = 0.001, respectively). The duration of fever before admission of patients in the neoplasm and collagen vascular disease group was longer than that of patients in the infectious disease group (p = and p = 0.007, respectively). The diagnostic time after admission of patients from the neoplasm and collagen vascular disease groups was longer than that for patients from the infectious disease group (both p < ). Serum ferritin levels of patients in the infectious disease group were lower than those of patients in the neoplasm and collagen vascular disease groups (p = and p = 0.032, respectively), while serum procalcitonin (PCT) levels in the infectious disease group was higher than that in the neoplasm and collagen vascular disease groups (p = and p = 0.007, respectively). Therefore, FUO remains a clinical problem in China and serum ferritin and PCT may be useful in discriminating infectious from non-infectious causes (neoplasms and collagen vascular diseases) in patients with FUO. INTRODUCTION Fever of unknown origin (FUO) was first defined by Petersdorf and Beeson as a body temperature higher than 38.39C, which last morethan 3 weeks, with a negative diagnostic evaluation after 1 week of investigation in the hospital (1). However, with a rise in the proportion of HIV-infected patients in addition to those with neutropenia and increasing opportunity to investigate FUO in an outpatient clinic, the definition was revised later by Durack and Street. They divided FUO into classic FUO, nosocomial FUO, neutropenic FUO, and HIV-associated FUO (2). FUO is a challenging clinical problem worldwide with a variety of etiologies and clinical manifestations. As diagnostic methods and tools are developed, most patients can reach a definite diagnosis. However, it is reported that 7z to 51z of FUO cases remain undiagnosed (3 13). There are more than 200 causes for FUO (14). Infectious diseases, neoplasms, and collagen vascular diseases are the main causes. In the past decade in China, infections were the most prevalent cause and collagen vascular diseases ranked second, followed by malignancy (5,6,15). However, Received September 20, Accepted December 21, J-STAGE Advance Publication January 8, DOI: /yoken.JJID *Corresponding author: Mailing address: Department of Infectious Diseases, Henan Province People's hospital, People's Hospital of Zhengzhou University, No. 7, Weiwu Road, Zhengzhou , Henan, China. Tel: , Fax: , shangjia666@ 126.com These two authors contributed equally to this study. despite the improvement of the diagnostic methods and tools, only a few studies on FUO have been published over the last decade. Furthermore, it remains unknown whether changes with respect to the markers for FUO have occurred in China. Obviously, fever is the common symptom of FUO, resulting from inflammation caused by biological factors, necrotic tissues, and allergy. Inflammatory markers, including white blood cell (WBC) count, C-reactive protein (CRP), erythrocyte sedimentation rates (ESR), serum ferritin, and serum procalcitonin (PCT), can increase to different levels when inflammation happens. Some of these non-specific laboratory tests may help excluding possible causes of FUO and narrowing down the range of diseases. However, a paucity of studies investigated changes in the levels of these inflammatory markers and whether some differences exist in the different etiologies of FUO. Therefore, we conducted a retrospective study to analyze the clinical and epidemiological data from patients with FUO in China in the latest years and to evaluate the diagnostic value of common inflammatory markers on FUO, which may help the diagnosis of FUO. MATERIALS AND METHODS Study population: This study was conducted at the Henan Province People's hospital in China and was approved by the Ethics Committee of the hospital. A total of 1,654 patients were hospitalized with fever as the chief complaint between January 2009 and June The patients were included in this study if they met the criteria of classical FUO defined by Petersdorf and Beeson: (i) body temperature higher than 38.39C, (ii) fever 378
2 Value of Inflammatory Markers on Fever of Unknown Origin lasting more than 3 weeks, (iii) with a negative diagnosis after 1 week of investigation in the hospital. Exclusion criteria were as follows: (i) Patients with neutropenia (neutrophil count < /L), (ii) patients who developed fever after being admitted to the hospital, (iii) patients with HIV. As a result, 383 (23.2z) patients with fever met the criteria and they were included in this study. Because the present study was merely observational and did not demand deviations from standard care, no informed consent was obtained. Data collection: We collected the data from the inpatient services at the Department of Infectious Diseases using the electronic medical record system and hospital paper charts. The epidemiological and clinical data recorded included sex, age, medical history, findings in physical examination, major causes, axillary temperature, duration of fever before admission, diagnostic methods, diagnostic time after admission, and duration of hospitalization. Besides, we collected all auxiliary tests carried out during the course of disease diagnosis, including complete blood count, peripheral blood smear, ESR, CRP, serum ferritin, PCT, biochemical tests (urea, creatinine, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, bilirubins, albumin, and globulin), urinalysis, tuberculin skin test, 3 sets of blood cultures, culture for urine, chest X-ray, computed tomography (CT), magnetic resonance imaging (MRI), PET/CT with 18F- FDG, and invasive procedures such as biopsies of the bone marrow, liver, and enlarged lymph nodes. ForserologicaltestsofpatientswithFUO,WBC count,crp,esr,serumferritin,andpctmeasured for the first time after admission were selected for the analysis in this study. WBC count was measured by XS- 800i Automatic Hematology Analyzer (SYSMEX Co., Hyogo, Japan). CRP was tested using an Automatic Biochemistry analyzer (Olympus AU2700, Olympus Corporation, Tokyo, Japan). ESR was determined by the Westergren method. Serum ferritin levels were measured by ARCHITECT T2000 SR equipment (ARCHITECT ferritin reagent kit, Abbott Ireland Diagnostics Division, Dublin, Ireland). Serum PCT was measured by immunochemiluminometric assays (LUMI test PCT, Brahms Diagnostica, Berlin, Germany). Patients confirmed as FUO were classified according to their final diagnoses into 5 groups, including infectious diseases, neoplasms, collagen vascular diseases, miscellaneous diseases, and no diagnosis. Statistical analysis: The data analyses were performed using the Statistical Package for Social Science Version 22.0 (SPSS Inc., Chicago, IL, USA). The normality of data distribution was assessed by Kolmogorov-Smirnov tests. The continuous variables following normal distribution were expressed as mean ± standard deviation and variables not following normal distribution were expressed as median and inter-quartile range. If the continuous variables followed normal distribution and homoscedasticity, one-way ANOVA was used to compare more than 2 groups and LSD-test was used to compare 2 groups. However, if the continuous variables did not follow a normal distribution or homoscedasticity, comparisons of multiple samples were analyzed by the Kruskal-Wallis test. When the results of the Kruskal- Wallis test were statistically significant, groups were reanalyzed using the Mann-Whitney test. Data were analyzed by sensitivity, specificity, positive andnegative likelihood ratios derived from the receiver operating characteristic (ROC) curve, and area under the ROC curve (AUC). All tests were 2-tailed, with the risk level set at 5z and statistical significance defined as p value of <0.05. RESULTS Table 1 shows the distribution of causes underlying FUO.Ofthe383cases,325 (84.9z) individuals reached a final diagnosis and,for 58 cases (15.1z), the diagnosis remained unknown. Infectious diseases, neoplasms, and collagen vascular diseases were the main etiologies of FUO. Infectious diseases were the most common and accounted for 33.9z of FUO cases, neoplasms for 21.1z, collagen vascular diseases for 25.1z, andmiscellaneous diseases for 4.7z. The most prevalent FUO Table 1. Causes of fever unknown origin Causes of fever Proportion (z) Infectious diseases 130 (33.9) Bacterial infection 101 (26.4) Tuberculosis 50 (13.1) Endocarditis 13 (3.4) Septicaemia 16 (4.2) Typhoid fever 6 (1.6) Brucellosis 5 (1.3) Urinary tract infection 5 (1.3) Intraabdominal abscess 4 (1.0) Actinomycosis 2 (0.5) Viral infection 16 (4.2) Parasitic infection 10 (2.6) Fungal infection 3 (0.8) Neoplasms 81 (21.1) Hodgkin lymphoma 10 (2.6) Non-Hodgkin lymphoma 45 (11.7) Leukaemia 11 (2.9) Hepatoma 2 (0.5) myeloma 1 (0.3) Pulmonary cacinoma 2 (0.5) Colon carcinoma 1 (0.3) Pancreatic carcinoma 1 (0.3) Malignant histiocytosis 6 (1.6) Malignancy of unknown primary 2 (0.5) Collagen vascular diseases 96 (25.1) Adult-onset Still disease 65 (17.0) Systemic lupus erythematosus 8 (2.1) Sjogren syndrome 5 (1.3) Polyarteritis nodosa 2 (0.5) Rheumatic arthritis 5 (1.3) Mixed connective tissue disease 3 (0.8) Undifferentiated connective tissue disease 3 (0.8) Vasculitis 2 (0.5) Polymyositis 3 (0.8) Miscellaneous diseases 18 (4.7) Subacute thyroiditis 3 (0.8) Necrotizing lymphadenitis 7 (1.8) Hemophagocytic syndrome 5 (1.3) Drug fever 3 (0.8) No diagnosis 58 (15.1) 379
3 Table 2. Patients' demographic characteristics of disease groups in diagnosed FUO (means ± SD) Infectious disease (n = 130) Neoplasm (n = 81) Collagen vascular disease (n = 96) Miscellaneous disease (n = 18) P-value Age (yrs) 42.8 ± ± ± ± 16.7 < Duration of fever before admission (days) 28.0 ± ± ± ± Duration of hospitalization (days) 24.9 ± ± ± ± Diagnostic time after admission (days) 11.3 ± ± ± ± 9.3 < FUO, fever unknown origin; SD, standard deviation. Table 3. Comparison of inflammatory makers' levels in disease groups (median [IQR] or [means ± SD]) Inflammatory marker Infectious disease (n = 130) Neoplasm (n = 81) Collagen vascular disease (n = 96) P-value White blood cell count ( 1,000/mm 3 ) 11.7 ( ) 11.0 ( ) 10.8 ( ) 0.76 C-reactive protein (mg/l) 82.4 ± ± ± Ferritin (ng/ml) ( ) 1,913.2 ( ,676.5) ( ,742.6) Erythrocyte sedimentation rate (mm/h) 68.2 ± ± ± Serum procalcitonin (ng/ml) 3.64 ± ± ± IQR, inter-quartile range; SD, standard deviation. causes were determined as non-hodgkin lymphoma, tuberculosis, and adult Still's disease in this order, accounting for 11.7z, 13.1z, and 17.0z of the cases, respectively. Among the 383 cases with FUO, the temperature fluctuated from a low temperature of 38.39C toahigh temperature of 41.59C. Irregular fever accounted for 60.0z, remittent fever for 26.4z, recurrent fever for 12.3z, and undulant fever for 1.3z of the cases. Ninety seven percent of patients presented with other symptoms such as chills, weakness, night sweats, pharyngalgia, cough, expectoration, myalgia, and arthralgia. Among the 325 (84.9z) patients with a final diagnosis, 108 (28.2z) patients were finally diagnosed mainly by serology or pathogen testing, 52 (13.6z)patientsbyimageology, 64 (16.7z) patients by pathology of bonemarrow, lymph node, liver, or skin biopsy, 75 (19.6z) cases by the effect of diagnostic treatment, 26 (6.8z) by medical history or the course of disease progression. Twelve patients were diagnosed by more than 2 bonemarrow or lymph node biopsies. Age, duration of fever before admission, and diagnostic time after admission significantly differed among the infectious disease, neoplasm, collagen vascular disease, and miscellaneous disease groups (p < , p = 0.006, and p < , respectively), while duration of hospitalization did not ( p = 0.054). Patients in the neoplasm group were older than those in the other 3 groups, including infectious disease, collagen vascular disease, and miscellaneous disease groups ( p = 0.006, p < , and p = 0.001, respectively). The duration of fever before admission of the patients in the neoplasm and collagen vascular disease groups was longer than that of the patients in the infectious disease group (p = and p = 0.007, respectively). The diagnostic time after admission of patients from the neoplasm and collagen vascular disease groups was longer than that of the patients in the infectious disease group (both p < ) (Table 2). No significant difference was observed in terms of WBC, CRP, and ESR between the infectious disease, neoplasm, and collagen vascular disease groups (p = 0.76, p = 0.32, and p = 0.26, respectively). However, serum ferritin and PCT levels were statistically different among the 3 groups (p = and p = 0.011, respectively). Serum ferritin levels of the infectious disease group were lower than those of the neoplasm and collagen vascular disease groups (p = and p = 0.032), while no significant difference was observed between the neoplasm and collagen vascular disease groups (p = 0.24). In contrast, serum PCT levels of the infectious disease group were higher than those of the neoplasm and collagen vascular disease groups ( p = and p = 0.007, respectively) (Table 3). Besides, PCT levels of patients with bacterial infections were higher than those of patients with non-bacterial infections (4.56 ± 0.58 vs. 0.43± 0.15 ng/ml, p = 0.007). Fig. 1 shows the ROC curve of inflammatory markers for discriminating infectious from non-infectious causes (neoplasms and collagen vascular diseases) in patients with FUO. The AUC of serum ferritin for noninfectious diseases was 0.78 (95z CI, ), with a sensitivity of 62z, a specificity of 83z, positive likelihood ratio of 3.65, and negative likelihood ratio of The AUC of PCT for infectious diseases was 0.92 (95z CI, ), with a sensitivity of 81z, a specificity of 88z, a positive likelihood ratio of 6.75, and a negative likelihood ratio of DISCUSSION FUO is a challenging clinical problem with a long course and much complex etiologies. Although the diagnostic methods and tools developed rapidly, the diagnostic time after admission is still very long and the cost is significantly high. More importantly, 7z to 51z of cases with FUO remained undiagnosed (15.1z reported inthisstudy).therefore,itisurgenttodeterminethe distribution of etiologies and their clinical data dynamically from patients with FUO and explore some detection indices for the differential diagnosis of FUO. In this study, the etiologies of FUO were identified as 380
4 Value of Inflammatory Markers on Fever of Unknown Origin Fig. 1. Receiver operating characteristic (ROC) curve of inflammatory markers for discriminating infectious from non-infectious causes in patients with fever of unknown origin. (A) ROC curve of serum ferritin for noninfectious diseases (neoplasms and collagen vascular diseases). (B) ROC curve of procalcitonin for infectious diseases. follows: infectious diseases, 33.9z; neoplasms, 21.1z; collagen vascular diseases, 25.1z; miscellaneous diseases, 4.7z; and unidentified, 15.1z. Infectionwasthe most common cause and collagen vascular diseases ranked second followed by malignancy. These 3 causes accounted for about 80z of all etiologies. The result was consistent with that of previous studies in China (5,6,15). About 84.9z of cases with FUO reached a definite diagnosis. The rate of definite diagnosis determined herein is higher than that previously reported (5,6), which can be attributed to the progress of diagnostic methods and tools such as the use of PET/CT with 18F-FDG (16 19). However, 15.1z of cases remained undiagnosed in this study. FUO is likely to remain a clinical problem and more advanced diagnostic techniques need to be explored. The present study showed that patients from the neoplasm group were the oldest among all cases with FUO. Therefore, clinicians should remain on high alert for neoplasm in the elderly with FUO. The duration of fever before admission and the diagnostic time after admission in the neoplasm and collagen vascular disease groups was longer than that of the infectious disease group. Adult Still's disease is the principal cause in the collagen vascular disease group, accounting for 67.7z (65/96) in this group. It usually lacks specific manifestations and its diagnosis is always based on clinical features after excluding other diseases (20). Therefore, its diagnostic time after admission is rather long. In this study, there were 55 cases with lymphoma, including non-hodgkin lymphoma and Hodgkin lymphoma, accounting for 67.9z (55/81) of the patients in the neoplasm group. Lymphoma is frequently lacking specific clinical presentations in the early stage. Although medical imaging technologies such as ultrasound, CT, and MRI greatly progressed, the diagnosis of lymphoma remained difficult. In some cases, biopsies from the bone marrow or enlarged lymph node have to be repeatedtwiceormoreforthediagnosisoflymphoma.asa result, the diagnostic time after admission is longer. Serum ferritin was discovered by Laufberger in 1937 and was first measured in serum by a radioimmunoassay (21). It is not only used as an index of the extent of iron storage in the body, but also as an acute phase reactant in response to inflammation (22). If serum ferritin is elevated, infectious diseases, neoplastic diseases, liver diseases, and hemophagocytic syndrome should be considered (23 25). Our study demonstrated that serum ferritin levels of patients in the infectious disease group were lower than those of patients in the neoplasm and collagen vascular disease groups (p = and p = 0.032, respectively). This result is in agreement with previous studies (11,26,27). Cunha et al. (26) asserted that serum ferritin levels should be used combined with medical history, physical examination, and other serological tests to exclude infections because the likelihood of infectious disease is low when early serum ferritin levels are elevated. Efstathiou et al. (11) reported that ferritin concentration <500 ng/ml, eosinopenia <40/mm 3, and CRP >6 mg/dl were independently associated with infectious diseases. Another study by Kim et al. (27) demonstrated that the median serum ferritin level in infectious diseases was lower than that in the hematologic disease group and noninfectious inflammatory diseases. The optimal cutoff value of serum ferritin levels to predict FUO caused by a noninfectious disease (hematologic diseases and noninfectious inflammatory diseases) was established as 561 ng/ml. In addition, Cunha et al. (26) recognized that serum ferritin is an acute phase reactant and ferritin levels may be elevated as part of the acute phase. However, the process of FUO is prolonged for more than 3 weeks according to the definition. Therefore, the authors considered that highly elevated serum ferritin levels should not be ascribed to an acute phase reaction occurring early in the first few days of an acute process, but rather are reflective of the disorder causing FUO in the FUO context. Hazard et al. (28) showed that patients with 381
5 hematologic malignancies presented with a reduced cellular immunity level and increased serum ferritin levels. They concluded that serum ferritin is associated with immunity. In addition, elevated serum ferritin is related to chronic inflammation such as hematologic malignancy or autoimmune diseases. When the chronic inflammation occurs, the body produces hepcidin in the liver to prevent the utilization of serum iron by pathogens or tumor cells by suppressing intestinal absorption and sequestration of iron in the macrophages, causing an increase in serum ferritin (27,29,30). Therefore, serum ferritin may be a useful index for the discrimination between infectious diseases and noninfectious diseases (neoplasms and collagen vascular diseases) in the treatment of patients with FUO. Our data also showed that serum PCT levels of patients in the infectious disease group were higher than that of patients in the neoplasm and collagen vascular disease groups ( p = 0.016and p = 0.007, respectively). The finding was not in line with the previous study by Naito et al. (31), probably due to the limited number of subjects in the previous study. PCT levels were measured in only 45 patients with FUO. PCT is the prohormone of calcitonin secreted by C cells in the thyroid in response to hypercalcemia (32). Its secretion is stimulated by various cytokines in systemic inflammatory conditions, especially, in bacterial infections, while the PCT production is decreased in viral infections, likely resulting from increased interferon gamma production (33). In addition, elevated PCT levels are not observed in noninfectious inflammatory conditions. The levels of PCT in bacterial infection conditions could be detectable within 3 4 hours and peak within 6 24 hours, which is earlier than both CRP and ESR. Simon et al. (34) recognized that serum PCT was particularly good for differentiating bacterial infections from viral infections and differentiating bacterial infections from other noninfectious causes of systemic inflammation. In our study, PCT levels of patients from the infectious disease group was higher than those of patients from other noninfectious disease groups resulting from the fact that the majority of the infectious diseases, about 76z (99/130), were bacterial infections. This result was in agreement with previous findings. Thus, PCT is also a valuable marker in differentiating infectious causes from non-infectious causes in patients with FUO. In addition, no significant differences were detected in the levels of WBC, CRP, and ESR among the infectious disease, neoplasm, and collagen vascular disease groups (p = 0.76, p = 0.32, and p = 0.26, respectively) in our study. These findings are in line with previous studies (27,31). Although these 3 indices would be elevated in inflammatory conditions, they are nonspecific for the differential diagnosis of FUO. Our study has some limitations. The results were obtained at a single hospital and there is a probability of selective bias. The results should be confirmed by multicenter studies due to the possibility of region-specific differences. Besides, we included only inflammatory markers measured for the first time after admission. They may fluctuate with time, which may influence the results of this study. In conclusion, with the progress in the development of diagnostic methods and tools, more and more patients with FUO are eventually diagnosed, but, for some, the origin of FUO remains unknown. FUO remains a clinical problem in China. Among the causes of FUO, it takes longer to diagnose neoplasms and collagen vascular diseases. Elevated serum ferritin levels in patients with FUO are associated with a low probability of an infectious disease and a high probability of a neoplasm and collagen vascular disease. In contrast, increased serum PCT level is associated with a higher probability of an infectious disease rather than a neoplasm or collagen vascular disease. Therefore, serum ferritin and serum PCT may be useful in discriminating infectious from non-infectious causes (including neoplasmsand collagen vascular diseases) in patients with FUO. Acknowledgments We gratefully thank for Hui-Bin Ning for collecting the data and Yan-Hong Kang for comments on the manuscript. This work was supported by the National Key Specialty Construction of Clinical Projects of China (2012). Conflict of interest None to declare. REFERENCES 1. Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore). 1961;40: Durack DT, Street AC. Fever of unknown origin reexamined and redefined. Curr Clin Top Infect Dis. 1991;11: Bleeker-Rovers CP, Vos FJ, de Kleijn EM, et al. A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore). 2007;86: Tabak F, Mert A, Celik AD, et al. Fever of unknown origin in Turkey. Infection. 2003;31: Liu KS, Sheng WH, Chen YC, et al. Fever of unknown origin: a retrospective study of 78 adult patients in Taiwan. J Microbiol Immunol Infect. 2003;36: Zhiyong Z, Bingjun L, Xiaoju L, et al. Fever of unknown origin: a report from China of 208 cases. Int J Clin Pract. 2003;57: Saltoglu N, Tasova Y, Midikli D, et al. Fever of unknown origin in Turkey: evaluation of 87 cases during a nine-year-period of study. J Infect. 2004;48: Ergonul O, Willke A, Azap A, et al. Revised definition of `fever of unknown origin': limitations and opportunities. J Infect. 2005; 50: ErtenN,SakaB,OzturkG,etal.Feverofunknownorigin:a report of 57 cases. Int J Clin Pract. 2005;59: Kucukardali Y, Oncul O, Cavuslu S, et al. The spectrum of diseases causing fever of unknown origin in Turkey: a multicenter study. Int J Infect Dis. 2008;12: Efstathiou SP, Pefanis AV, Tsiakou AG, et al. Fever of unknown origin: discrimination between infectious and non-infectious causes. Eur J Intern Med. 2010;21: Naito T, Mizooka M, Mitsumoto F, et al. Diagnostic workup for fever of unknown origin: a multicenter collaborative retrospective study. BMJ Open. 2013;3:e Yamanouchi M, Uehara Y, Yokokawa H, et al. Analysis of 256 cases of classic fever of unknown origin. Intern Med. 2014;53: Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Intern Med. 2003;253: Hu Y, Lu H, Zhang Y, et al. Fever of unknown origin: revisit of 142 cases in a tertiary Chinese hospital. Biosci Trends. 2008;2: Roy SG, Karunanithi S, Dhull VS, et al. 18 F-FDG PET/CT aids the diagnosis of adult onset Still's disease in a patient with fever of unknown origin. Rev Esp Med Nucl Imagen Mol. 2014;33: Krem MM, Pan L, Blinder MA. 18 F-FDG-PET-facilitated diagnosis of lymphoma presenting with fever of unknown origin and cold agglutination. Leuk Lymphoma. 2007;48: Gafter-Gvili A, Raibman S, Grossman A, et al. [18F] FDG- 382
6 Value of Inflammatory Markers on Fever of Unknown Origin PET/CT for the diagnosis of patients with fever of unknown origin. QJM. 2015;108: Buch-Olsen KM, Andersen RV, Hess S, et al. 18F-FDG-PET/CT in fever of unknown origin: clinical value. Nucl Med Commun. 2014;35: Larkin JG, Sturrock RD. Adult Still's disease. A new consideration in pyrexia of unknown origin. Scott Med J. 1983;28: Addison GM, Beamish MR, Hales CN, et al. An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. J Clin Pathol. 1972;25: Tran TN, Eubanks SK, Schaffer KJ, et al. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood. 1997;90: Koduri PR, Carandang G, DeMarais P, et al. Hyperferritinemia in reactive hemophagocytic syndrome report of four adult cases. Am J Hematol. 1995;49: Lee MH, Means RT Jr. Extremely elevated serum ferritin levels in a university hospital: associated diseases and clinical significance. Am J Med. 1995;98: Di Bisceglie AM, Axiotis CA, Hoofnagle JH, et al. Measurements of iron status in patients with chronic hepatitis. Gastroenterology. 1992;102: Cunha BA. Diagnostic significance of non-specific laboratory abnormalities in infectious diseases. In:Gorbach SL, Bartlett JG, Blacklow NR, editors. Infectious Diseases. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; p Kim SE, Kim UJ, Jang MO, et al. Diagnostic use of serum ferritin levels to differentiate infectious and noninfectious diseases in patients with fever of unknown origin. Dis Markers. 2013;34: Hazard JT, Drysdale JW. Ferritinaemia in cancer. Nature. 1977; 265: Zandman-Goddard G, Shoenfeld Y. Ferritin in autoimmune diseases. Autoimmun Rev. 2007;6: Ganz T, Nemeth E. Iron sequestration and anemia of inflammation. Semin Hematol. 2009;46: Naito T, Torikai K, Mizooka M, et al. Relationships between causes of fever of unknown origin and inflammatory markers: a multicenter collaborative retrospective study. Intern Med. 2015; 54: Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem. 2001;38: Gilbert DN. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis. 2011;52 Suppl 4:S Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C- reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:
NUCLEAR MEDICINE IMAGING IN FUO
NUCLEAR MEDICINE IMAGING IN FUO Christophe Van de Wiele, M.D., Ph.D. Department of Nuclear Medicine, University Hospital, Ghent, Belgium NUCLEAR MEDICINE IMAGING IN FUO Definitions and classifications
More informationThe Role of Invasive and Non-Invasive Procedures in Diagnosing Fever of Unknown Origin
Ivyspring International Publisher Research Paper 682 International Journal of Medical Sciences 2012; 9(8):682-689. doi: 10.7150/ijms.4591 The Role of Invasive and Non-Invasive Procedures in Diagnosing
More informationFEVER OF UNKNOWN ORIGIN. Cristian Baicus Internal Medicine, Colentina Hospital
FEVER OF UNKNOWN ORIGIN Cristian Baicus Internal Medicine, Colentina Hospital www.baicus.ro 1961 definition 1. Ilness> 3 weeks 2. Fever>38.3 C (>101 F), on several occasions 3. Diagnosis uncertain after
More informationFever in Lupus. 21 st April 2014
Fever in Lupus 21 st April 2014 Fever in lupus Cause of fever N= 487 % SLE fever 206 42 Infection in SLE 265 54.5 Active SLE and infection 8 1.6 Tumor fever 4 0.8 Miscellaneous 4 0.8 Crucial Question Infection
More informationRelationships between Causes of Fever of Unknown Origin and Inflammatory Markers: A Multicenter Collaborative Retrospective Study
ORIGINAL ARTICLE Relationships between Causes of Fever of Unknown Origin and Inflammatory Markers: A Multicenter Collaborative Retrospective Study Toshio Naito 1, Keito Torikai 2, Masafumi Mizooka 3, Fujiko
More informationDiagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography / computed tomography in fever of unknown origin
175 18 F-FDG PET /CT 1* 2* 1 1 1 1 1 1 1. 100034 2. 100850 18 F-FDG PET /CT fever of unknown origin FUO 2010 8 2013 4 51 FUO FDG PET /CT 3 FDG PET /CT t 51 FUO 32 9 7 3 FDG PET FUO 27 52. 9% 14 27. 5%
More informationEtiology and Resource Use of Fever of Unknown Origin in Hospitalized Children
RESEARCH ARTICLE Etiology and Resource Use of Fever of Unknown Origin in Hospitalized Children James W. Antoon, MD, PhD, a David C. Peritz, MD, b Michael R. Parsons, MD, c Asheley C. Skinner, PhD, d Jacob
More informationRecent trends in the distribution of causative diseases of fever of unknown origin
Wien Klin Wochenschr (2017) 129:201 207 DOI 10.1007/s00508-016-1159-6 Recent trends in the distribution of causative diseases of fever of unknown origin Jin Shang Libo Yan Lingyao Du Lingbo Liang Qiaoling
More informationProcalcitonin YUKON KUSKOKWIM HEALTH CORPORATION PRESENTED BY: CURT BUCHHOLZ, MD AUGUST 2017
Procalcitonin YUKON KUSKOKWIM HEALTH CORPORATION PRESENTED BY: CURT BUCHHOLZ, MD AUGUST 2017 Procalcitonin (PCT) PCT isbeing studied as a biomarker for infection PCT consists of 116 amino
More informationClinical features and outcomes of patients with fever of unknown origin: a retrospective study
Tan et al. BMC Infectious Diseases (2019) 19:198 https://doi.org/10.1186/s12879-019-3834-5 RESEARCH ARTICLE Open Access Clinical features and outcomes of patients with fever of unknown origin: a retrospective
More informationPFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert.
PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. GENERIC DRUG NAME / COMPOUND NUMBER: Tofacitinib / CP-690,550
More informationDisclosures. Learning Objectives: Marker for Inflammation
39 th National Conference on Pediatric Health Care March 19-22, 2018 CHICAGO Inflammatory Markers: When and What to Order and What to Do With the Number None to disclose Disclosures Cathy S. Woodward,
More informationInternal Medicine Certification Examination Blueprint
Internal Medicine Certification Examination Blueprint What Does the Examination Cover? The exam is designed to evaluate the extent of the candidate s knowledge and clinical judgment in the areas in which
More informationFever of unknown origin
Fever of unknown origin Case B History of the present illness 75 years old women presented at our hospital with since months daily fevers between 38 to 39.5 Celsius (100.4-103.1 F) with night sweats. Her
More informationPathology of Hematopoietic and Lymphoid tissue
CONTENTS Pathology of Hematopoietic and Lymphoid tissue White blood cells and lymph nodes Quantitative disorder of white blood cells Reactive lymphadenopathies Infectious lymphadenitis Tumor metastasis
More informationLeukocytosis. dr. Erdélyi, Dániel 2 nd Department of Paediatrics Semmelweis University
Leukocytosis dr. Erdélyi, Dániel 2 nd Department of Paediatrics Semmelweis University My first day at work in 1997 3y with fever, cough Is this bronchitis, pneumonia, pharyngitis, sinusitis, else? Is this
More informationDISCLOSURE. Relevant relationships with commercial entities none. Potential for conflicts of interest within this presentation none
FEVER DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none Steps taken to review and mitigate potential bias N/A LEARNING OBJECTIVE
More informationCHAPTER 11 FEVER. Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University
CHAPTER 11 FEVER Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University DEFINITION OF FEVER Fever is an elevation of body temperature that exceeds the normal daily variation,
More informationFever is one of the common presenting symptom in clinical practice. Most of the. Clinical profile of classical Fever of unknown origin (FUO)
Short Communication Clinical profile of classical Fever of unknown origin (FUO) Tanveer Mir (MD) *1 Gulam Nabi Dhobi (MD) 1 Ajaz Nabi Koul (MD, MRCP, FCAN) 1 Tajamul Saleh (MD) 1 1- Department of Medicine,
More informationEarly Klebsiella pneumoniae Liver Abscesses associated with Pylephlebitis Mimic
Early Klebsiella pneumoniae Liver Abscesses associated with Pylephlebitis Mimic Hepatocellular Carcinoma Chih-Hao Shen, MD 3, Jung-Chung Lin, MD, PhD 2, Hsuan-Hwai Lin, MD 1, You-Chen Chao, MD 1, and Tsai-Yuan
More informationClinical Manifestations of Kawasaki Disease: What Are the Significant Parameters?
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY (2009) 27: 131-136 Clinical Manifestations of Kawasaki Disease: What Are the Significant Parameters? Kanoknaphat Chaiyarak 1, Kritvikrom Durongpisitkul 2,
More informationPathology of Hematopoietic and Lymphoid tissue
Pathology of Hematopoietic and Lymphoid tissue Peerayut Sitthichaiyakul, M.D. Department of Pathology and Forensic Medicine Faculty of Medicine, Naresuan University CONTENTS White blood cells and lymph
More informationEvaluation of Neck Mass. Disclosure. Learning Objectives 3/24/2014. Karen T. Pitman MD, FACS Banner MDACC, Gilbert AZ. Nothing to disclose
Evaluation of Neck Mass Karen T. Pitman MD, FACS Banner MDACC, Gilbert AZ Nothing to disclose Disclosure Learning Objectives 1. Describe a systematic method to evaluate a patient with a neck mass 2. Select
More informationMC 1 Pyrexia of unknown origin
MC 1 Pyrexia of unknown origin Pyrexia of unknown origin Clinical history, physical examination, laboratory tests, CXR Specific diagnosis established? Yes No Order appropriate investigations Further investigations
More informationDiagnostic approach to fever of unknown origin. Steven Vanderschueren General Internal Medicine University Hospitals Leuven Belgium
Diagnostic approach to fever of unknown origin Steven Vanderschueren General Internal Medicine University Hospitals Leuven Belgium FUO A Case Definitions Causes Diagnostic Approach Prognosis Conclusion
More informationSERUM FERRITIN LEVELS IN CHILDREN WITH DENGUE INFECTION
SERUM FERRITIN LEVELS IN CHILDREN WITH DENGUE INFECTION Wathanee Chaiyaratana 1, Ampaiwan Chuansumrit 2, Kalayanee Atamasirikul 3 and Kanchana Tangnararatchakit 2 1 Research Center, 2 Department of Pediatrics,
More informationApplications of PET/CT in Rheumatology. Role of PET/CT. Annibale Versari, MD Nuclear Medicine PET Center S.Maria Nuova Hospital Reggio Emilia Italy
CME Session Associazione Italiana di Medicina Nucleare ed Imaging Molecolare Applications of PET/CT in Rheumatology Role of PET/CT Annibale Versari, MD Nuclear Medicine PET Center S.Maria Nuova Hospital
More informationRAPIDLY FAILING KIDNEYS. Dr Paul Johny 2 nd yr DNB Medicine Resident
RAPIDLY FAILING KIDNEYS Dr Paul Johny 2 nd yr DNB Medicine Resident Mr Z 67yrs old Occupation : Retired officer from electricity board Chief complaints : Fever : 5 days Right lower limb swelling and pain
More informationReactive thrombocytosis in children
The Turkish Journal of Pediatrics 2013; 55: 411-416 Original Reactive thrombocytosis in children Celal Özcan 1, Tülin Revide Şaylı 2, Vildan Koşan-Çulha 2 2 Division of Pediatric Hematology, 1 Department
More informationLaboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland
Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland Sanjiv Chopra, MD, MACP Professor of Medicine Harvard Medical School Editor In Chief Hepatology Section Up To Date Serum
More informationSerial serum procalcitonin changes in the prognosis of acute stroke
University of Wollongong Research Online Faculty of Science, Medicine and Health - Papers Faculty of Science, Medicine and Health 2004 Serial serum procalcitonin changes in the prognosis of acute stroke
More informationDiseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:
Diseases of liver Dr. Mohamed. A. Mahdi Mob: 0123002800 4/2/2019 Cirrhosis Cirrhosis is a complication of many liver disease. Permanent scarring of the liver. A late-stage liver disease. The inflammation
More informationAUTOIMMUNE DISORDERS IN THE ACUTE SETTING
AUTOIMMUNE DISORDERS IN THE ACUTE SETTING Diagnosis and Treatment Goals Aimee Borazanci, MD BNI Neuroimmunology Objectives Give an update on the causes for admission, clinical features, and outcomes of
More informationLymphoma Case Scenario 1
Lymphoma Case Scenario 1 HISTORY: A 23-year-old healthy female presented with a month-long history of persistent headache of increasing severity. She noted episodic nausea and vomiting in association with
More informationJ of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 37/Aug 21, 2014 Page 9580
THE SPECTRUM OF CERVICAL LYMPHADENOPATHY IN CHILDREN: A STUDY IN RURAL NORTH INDIA Pawan Tiwari 1, Satya Kiran Kapoor 2, Madhu Tiwari 3, Yogesh Yadav 4 HOW TO CITE THIS ARTICLE: Pawan Tiwari, Satya Kiran
More informationAbstracting Hematopoietic Neoplasms
CASE 1: LYMPHOMA PHYSICAL EXAMINATION 43yo male with a history of lower gastrointestinal bleeding and melena undergoing colonoscopy and biopsy to rule out neoplasm versus inflammation. Patient had no other
More informationCombined efficacy of pleural fluid lymphocyte neutrophil ratio and pleural fluid adenosine deaminase for the diagnosis of tubercular pleural effusion
Original article: Combined efficacy of pleural fluid lymphocyte neutrophil ratio and pleural fluid adenosine deaminase for the diagnosis of tubercular pleural effusion Kavita S Kore, Guruprasad Antin,
More informationApproach to the Patient with Liver Disease
Approach to the Patient with Liver Disease Diagnosis of liver disease Careful history taking Physical examination Laboratory tests Radiologic examination and imaging studies Liver biopsy Liver diseases
More informationCancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006
Chinese Journal of Cancer Original Article Cancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006 Xiao-Pan Li 1, Guang-Wen Cao 2, Qiao
More informationLymphatic System Disorders
Lymphatic System Disorders Lymphomas Malignant neoplasms involving lymphocyte proliferation in lymph nodes Specific causes not identified // Higher risk in adults who received radiation during childhood
More informationClinical outcome and predictive factors of recurrence among patients with Kikuchi s disease
International Journal of Infectious Diseases (2009) 13, 322 326 http://intl.elsevierhealth.com/journals/ijid Clinical outcome and predictive factors of recurrence among patients with Kikuchi s disease
More informationPCT. PCT in Bacterial Infections and Sepsis. Early Diagnosis. Assessment of Severity and Prognosis. Support for Therapeutic Decision Making
PCT PCT in Bacterial Infections and Sepsis Early Diagnosis Assessment of Severity and Prognosis Support for Therapeutic Decision Making Diagnosis and monitoring of sepsis Clinical need for earlier detection
More informationPROFILE OF PAEDIATRIC PATIENTS WITH CERVICAL LYMPHADENOPATHY: A STUDY FROM CENTRAL INDIA Jharna Mishra 1, M. Maheshwari 2, Roshan Chanchlani 3
PROFILE OF PAEDIATRIC PATIENTS WITH CERVICAL LYMPHADENOPATHY: A STUDY FROM CENTRAL INDIA Jharna Mishra 1, M. Maheshwari 2, Roshan Chanchlani 3 HOW TO CITE THIS ARTICLE: Jharna Mishra, M. Maheshwari, Roshan
More informationMalignancies in Korean Patients with Inflammatory Myopathy
Yonsei Medical Journal Vol. 47, No. 4, pp. 519-523, 2006 Malignancies in Korean Patients with Inflammatory Myopathy Sang-Won Lee, Sang Youn Jung, Min-Chan Park, Yong-Beom Park, and Soo-Kon Lee Division
More informationXiao-Ling Chi, Mei-Jie Shi, Huan-Ming Xiao, Yu-Bao Xie, and Gao-Shu Cai. Correspondence should be addressed to Xiao-Ling Chi;
Evidence-Based Complementary and Alternative Medicine Volume 2016, Article ID 3743427, 6 pages http://dx.doi.org/10.1155/2016/3743427 Research Article The Score Model Containing Chinese Medicine Syndrome
More informationReferral Form CPFT Chronic Fatigue Syndrome / Myalgic Encephalomyelitis Service (CFS/ME) for Adults
Referral Form CPFT Chronic Fatigue Syndrome / Myalgic Encephalomyelitis Service (CFS/ME) for Adults Please note: Failure to include all Information required may result in your referral being rejected.
More informationUsefulness of Procalcitonin in the management of Infections in ICU. P Damas CHU Sart Tilman Liège
Usefulness of Procalcitonin in the management of Infections in ICU P Damas CHU Sart Tilman Liège Procalcitonin Peptide 116 AA Produced by parenchymal cells during «sepsis»: IL1, TNF, IL6 : stimulators
More informationCutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients
ORIGINAL ARTICLE Korean J Intern Med 215;3:198-24 Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients Wan Soo Lee, Dae Woong Kang, Jong Hun Back,
More informationChapter 22. Pulmonary Infections
Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired
More informationKIDNEY FAILURE. What causes kidney failure People who are most at risk for kidney failure usually have one or more of the following causes:
KIDNEY FAILURE Your kidneys are a pair of organs located toward your lower back. One kidney is on each side of your spine. They filter your blood and remove toxins from your body. Your kidneys send toxins
More informationLiver Disease. By: Michael Martins
Liver Disease By: Michael Martins Recently I have been getting a flurry of patients that have some serious liver complications. This week s literature review will be the dental management of the patients
More information* MILIARY MOTTLING --
* MILIARY MOTTLING -- RARE CAUSE DR ARATHI SRINIVASAN FELLOW IN PEDIATRIC HEMATO ONCOLOGY DR A ANDAL DEPARTMENT OF PEDIATRICS DR JULIUS XAVIER SCOTT DEPARTMENT OF PEDIATRIC HEMATO ONCOLOGY KANCHI KAMAKOTI
More informationVasculitides in Surgical Neuropathology Practice
Vasculitides in Surgical Neuropathology Practice USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS
More informationL utilizzo della Procalcitonina in Medicina d Urgenza
L utilizzo della Procalcitonina in Medicina d Urgenza Stefania Battista Dirigente Medico S.C. Medicina d Urgenza Azienda Ospedaliero-Universitaria San Giovanni Battista di Torino Savona, 15 ottobre 2009
More informationInfection Imaging In Nuclear Medicine: Arguing The Case for PET/CT.
Infection Imaging In Nuclear Medicine: Arguing The Case for PET/CT. LUIS A. TAMARA M.D. NUCLEAR MEDICINE /PET-CT SERVICE CHIEF MEDVAMC DISCLOSURES. 2 3 Not difficult to appreciate the difference! GA-67
More informationAccepted Manuscript. Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: too alarming?
Accepted Manuscript Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: too alarming? Qing-Lei Zeng, Zhi-Qin Li, Hong-Xia Liang, Guang-Hua Xu, Chun-Xia
More information[DOI] /j.issn
56 2018 1 1431 - [ ]- - T- SPOT.TB 5638 18T-SPOT.TB T-SPOT.TB86.5%(95%CI 71.2%~95.5%) 100%(95%CI 90.5%~100%) 52.9%(95%CI 27.8%~77.0%) 35.3%(95%CI 14.2%~61.7%) 80.0%(95%CI 64.4%~90.9%) 77.1%(95%CI 62.7%~88.0%)
More informationComparison of three mathematical prediction models in patients with a solitary pulmonary nodule
Original Article Comparison of three mathematical prediction models in patients with a solitary pulmonary nodule Xuan Zhang*, Hong-Hong Yan, Jun-Tao Lin, Ze-Hua Wu, Jia Liu, Xu-Wei Cao, Xue-Ning Yang From
More informationCharacteristics of Patients Initializing Peritoneal Dialysis Treatment From 2007 to 2014 Analysis From Henan Peritoneal Dialysis Registry data
DIALYSIS Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 7 to 14 Analysis From Henan Peritoneal Dialysis Registry data Xiaoxue Zhang, 1 Ying Chen, 1,2 Yamei Cai, 1 Xing Tian,
More informationComparison between ESR and C-Reactive Protein(CRP) as a Marker of Disease activity in Patients with Rheumatoid Arthritis
Original Article Comparison between ESR and C-Reactive Protein(CRP) as a Marker of Disease activity in Patients with Rheumatoid Arthritis Ali M.E. Yousef 1, Fatemah A. Elshabacy 2, Sherry K. Abdelrahman
More informationValidation of Clinical Outcomes in Electronic Data Sources
Validation of Clinical Outcomes in Electronic Data Sources Vincent Lo Re, MD, MSCE Assistant Professor of Medicine and Epidemiology Center for Clinical Epidemiology and Biostatistics Center for Pharmacoepidemiology
More informationInvestigating the recheck rules for urine analysis in children
Investigating the recheck rules for urine analysis in children Y.M. He*, S.W. Yao*, Y.J. Huang, B.S. Liang and H.Y. Liu Clinical Laboratory, Guangzhou Women and Children s Medical Center, Guangzhou Medical
More informationThe Naproxen Test as a Diagnostic Tool in the Causative Differentiation of Fever
The Naproxen Test as a Diagnostic Tool in the Causative Differentiation of Fever Emmanuel Edwin R. Dy, M.D.,* Patrick Gerard L. Moral, M.D.** and Sandra Teresa G. Victorio-Navarra, M.D.*** (*Fellow, Section
More informationAspartate aminotransferase-to-platelet ratio index in children with cholestatic liver diseases to assess liver fibrosis
The Turkish Journal of Pediatrics 2015; 57: 492-497 Original Aspartate aminotransferase-to-platelet ratio index in children with cholestatic liver diseases to assess liver fibrosis Aysel Ünlüsoy-Aksu 1,
More information[ ] 203. (splenomegaly) 44 B. angioma) 2010; 20: splenomegaly, littoral cell angioma, splenectomy [3] [1,2]
[] 203 1 1,4 1,4 2,4 3 (splenomegaly) 44 B (splenectomy)(littoral cell angioma) 2010; 20: 203-210 splenomegaly, littoral cell angioma, splenectomy [1,2] [3] 1 2 3 4 99 9 6 99 11 7 92 Taiwan J Fam Med 204
More informationORIGINAL INVESTIGATION. From Prolonged Febrile Illness to Fever of Unknown Origin
From Prolonged Febrile Illness to Fever of Unknown Origin The Challenge Continues ORIGINAL INVESTIGATION Steven Vanderschueren, MD, PhD; Daniël Knockaert, MD, PhD; Tom Adriaenssens, MD; Wim Demey, MD;
More informationSupplementary materials
Supplementary materials Table S Adverse events identified by participants diary logs and blood hematologic and biochemical tests (n=2) group (n=) Placebo group (n=) P value for chi-squared test Asthma
More informationITO, Yasuhiro ; FUJII, Mizue ; SHIBUYA, Takashi ; UEHARA, Jiro ; SATO, Katsuhiko ; IIZUKA, Hajime
Journal of Dermatology (2011) 38(5):515-517. Granulocyte colony stimulating factor-producing squamous cell carcinoma of the skin ITO, Yasuhiro ; FUJII, Mizue ; SHIBUYA, Takashi ; UEHARA, Jiro ; SATO, Katsuhiko
More informationSignificance of Anti-C1q Antibodies in Patients with Systemic Lupus Erythematosus as A Marker of Disease Activity and Lupus Nephritis
THE EGYPTIAN JOURNAL OF IMMUNOLOGY Vol. 23 (1), 2016 Page: 00-00 Significance of Anti-C1q Antibodies in Patients with Systemic Lupus Erythematosus as A Marker of Disease Activity and Lupus Nephritis 1
More informationCERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION In terms of section 22(2) (b) of the Accreditation for Conformity Assessment, Calibration and Good Laboratory Practice Act, 2006 (Act 19 of 2006), read with sections 23(1),
More informationLixin Yang, 1 Jing Liu, 2 Yun Xing, 1 Lichuan Du, 1 Jing Chen, 1 Xin Liu, 3 and Jianyu Hao Introduction. 2. Material and Method
Hindawi Publishing Corporation Gastroenterology Research and Practice Volume 2016, Article ID 1834256, 7 pages http://dx.doi.org/10.1155/2016/1834256 Research Article Comparison of,,, and in Predicting
More informationUndifferentiated epithelioid sarcoma presenting as a fever of unknown origin: a case report
Sajko et al. Journal of Medical Case Reports (2019) 13:24 https://doi.org/10.1186/s13256-018-1951-1 CASE REPORT Undifferentiated epithelioid sarcoma presenting as a fever of unknown origin: a case report
More informationLong-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance
Long-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance Gi-Ae Kim, Han Chu Lee *, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim,
More informationPFIZER INC. These results are supplied for informational purpose only. Prescribing decisions should be made based on the approved package insert.
Public Disclosure Synopsis Protocol A3924 4 November 24 Final PFIZER INC. These results are supplied for informational purpose only. Prescribing decisions should be made based on the approved package insert.
More informationResearch Article Hyperferritinemia as a Diagnostic Marker for Severe Fever with Thrombocytopenia Syndrome
Hindawi Publishing Corporation Disease Markers Volume 217, Article ID 6727184, 6 pages http://dx.doi.org/1.1155/217/6727184 Research Article Hyperferritinemia as a Diagnostic Marker for Severe Fever with
More informationunknown origin Summary Background [18F] FDG-PET/CT for the diagnosis of patients with fever of
Q J Med 2015; 108:289 298 doi:10.1093/qjmed/hcu193 Advance Access Publication 10 September 2014 [18F] FDG-PET/CT for the diagnosis of patients with fever of unknown origin A. GAFTER-GVILI 1,2,3 *, S. RAIBMAN
More informationClinical Value of C-reactive Protein and Erythrocyte Sedimentation Rate in Advanced Bladder Cancer
Original Article Research in Oncology 2018; Vol. XX, No. X: X-X. DOI: 10.21608/resoncol.2018.4152.1060 Clinical Value of C-reactive Protein and Erythrocyte Sedimentation Rate in Advanced Bladder Cancer
More information8/11/16. Kevin Letz DNP, MSN, MBA, RN, CEN, CNE, FNP-C, PCPNP-BC, ANP-BC, FAANP
Kevin Letz DNP, MSN, MBA, RN, CEN, CNE, FNP-C, PCPNP-BC, ANP-BC, FAANP Eosinophilia Eosinophilia refers to an absolute eosinophil count in the peripheral blood of 500 eosinophils/microl; this is considered
More informationDr Sneha Shah Tata Memorial Hospital, Mumbai.
Dr Sneha Shah Tata Memorial Hospital, Mumbai. Topics covered Lymphomas including Burkitts Pediatric solid tumors (non CNS) Musculoskeletal Ewings & osteosarcoma. Neuroblastomas Nasopharyngeal carcinomas
More informationCHAPTER 3 DEATHS. Stephen McDonald Leonie Excell Brian Livingston
CHAPTER 3 DEATHS Stephen McDonald Leonie Excell Brian Livingston DEATHS ANZDATA Registry 2008 Report INTRODUCTION AUSTRALIA NEW ZEALAND The total number of deaths was 1,452 (15.4 deaths per 100 patient
More informationIdiopathic inflammatory myopathies
Myositis and cancer Idiopathic inflammatory myopathies Primary idiopathic polymyositis Primary idiopathic dermatomyositis Juvenile poly/dermatomyositis Myositis associated with another CTD Myositis associated
More informationWarm Autoantibodies in a Patient with Hemophagocytic Lymphohistiocytosis: A Case Report
Warm Autoantibodies in a Patient with Hemophagocytic Lymphohistiocytosis: A Case Report Emily Coberly, MD Department of Pathology and Anatomical Sciences University of Missouri Columbia April 30, 2013
More informationCOHORT STUDY OF HIV POSITIVE AND HIV NEGATIVE TUBERCULOSIS in PENANG HOSPITAL: COMPARISON OF CLINICAL MANIFESTATIONS
COHORT STUDY OF HIV POSITIVE AND HIV NEGATIVE TUBERCULOSIS in PENANG HOSPITAL: COMPARISON OF CLINICAL MANIFESTATIONS Ong CK 1, Tan WC 2, Leong KN 2, Abdul Razak M 1, Chow TS 2 1 Respiratory Unit, Penang
More informationLOKUN! I got stomach ache!
LOKUN! I got stomach ache! Mr L is a 67year old Chinese gentleman who is a non smoker, social drinker. He has a medical history significant for Hypertension, Hyperlipidemia, Type 2 Diabetes Mellitus, Chronic
More informationThe Harada Score in the US Population of Children With Kawasaki Disease
RESEARCH ARTICLE The Harada Score in the US Population of Children With Kawasaki Disease AUTHORS Helen Tewelde, MD, 1 Jeein Yoon, MD, 2 Wendy Van Ittersum, MD, 2 Sarah Worley, MS, 3 Tamar Preminger, MD,
More informationResearch Article In Critically Ill Patients, Serum Procalcitonin Is More Useful in Differentiating between Sepsis and SIRS than CRP, Il-6, or LBP
Critical Care Research and Practice Volume 2011, Article ID 594645, 6 pages doi:10.1155/2011/594645 Research Article In Critically Ill Patients, Serum Procalcitonin Is More Useful in Differentiating between
More informationCase of the Day Chest
Case of the Day Chest Darin White MDCM FRCPC Department of Radiology, Mayo Clinic 76 th Annual Scientific Meeting Canadian Association of Radiologists Montreal, QC April 26, 2013 2013 MFMER slide-1 Disclosures
More informationFever and rash in children. Haider Arishi MD Consultant, pediatrics and infectious diseases Director, infection control program
Fever and rash in children Haider Arishi MD Consultant, pediatrics and infectious diseases Director, infection control program objectives To understand importance of fever and rash. To discuss the clinical
More informationHodgkin's Lymphoma. Symptoms. Types
Hodgkin's lymphoma (Hodgkin's disease) usually develops in the lymphatic system, a part of the body's immune system. This system carries disease-fighting white blood cells throughout the body. Lymph tissue
More informationHELPING YOU AND YOUR PATIENTS TALK OPENLY ABOUT MODERATELY TO SEVERELY ACTIVE RA
SIMPONI ARIA (golimumab) is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) in combination with MTX, active psoriatic arthritis, and active ankylosing
More informationBIOMARKERS IN SEPSIS
BIOMARKERS IN SEPSIS Dr. Syed Ghulam Mogni Mowla Assistant Professor, Medicine, DMC BSMCON 17 WHY WE NEED TO KNOW Sepsis and its complications are a common cause of infectious disease illness and mortality
More informationSemi-quantitative Procalcitonin Test for the Diagnosis of Bacterial Infection: Clinical Use and Experience in Japan
Also available online http://www.e-jmii.com ISSN 1684-1182 Volume 43 Number 3 June 2010 Indexed in MEDLINE/Medicus, SCIE, BIOSIS, EMBASE, Aidsline, CancerLit, Chemical Abstracts, HealthSTAR The official
More informationDiagnosis and Medical Management of Latent TB Infection
Diagnosis and Medical Management of Latent TB Infection Marsha Majors, RN September 7, 2017 TB Contact Investigation 101 September 6 7, 2017 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Marsha Majors,
More informationUtilizing Sysmex RET He to Evaluate Anemia in Cancer Patients
Utilizing Sysmex RET He to Evaluate Anemia in Cancer Patients Ellinor I. Peerschke, Ph.D., F.A.H.A. Vice Chair, Laboratory Medicine Chief, Hematology & Coagulation Laboratory Services Memorial Sloan Kettering
More informationFever of Unknown Origin
Fever of Unknown Origin Dr. Kaya Süer Near East University Faculty of Medicine Infectious Diseases and Clinical Microbiology FUO Most episodes of fever in humans are short-lived do not require diagnostic
More informationCase report Fever in a patient with ANCA-associated vasculitis
Case report Fever in a patient with ANCA-associated vasculitis 73 years-old white woman PRIOR MEDICAL HISTORY *Hypertension: Enalapril, Furosemide *Dyslipidemia: Pravastatin *Ischemic heart disease: 2008
More informationpatients with urinary tract infection and distended bladder
J of Nuclear Medicine Technology, first published online December 23, 2014 as doi:10.2967/jnmt.114.148031 Interesting layering of excreted 18 F-FDG in the urinary bladder in patients with urinary tract
More informationSupplemental Figure 1. Gating strategies for flow cytometry and intracellular cytokinestaining
Supplemental Figure 1. Gating strategies for flow cytometry and intracellular cytokinestaining of PBMCs. Forward scatter area (FSC-A) versus side scatter area (SSC-A) was used to select lymphocytes followed
More information